These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 34721404)

  • 1. Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.
    Zhang Y; Xu Q; Chen L; Chen J; Zhang J; Zou Y; Gong T; Ji C
    Front Immunol; 2021; 12():738907. PubMed ID: 34721404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of dupilumab combined with methylprednisolone in the treatment of bullous pemphigoid in China.
    Qi W; Rushan X
    Int Immunopharmacol; 2023 May; 118():110050. PubMed ID: 37003187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab combined with low-dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid.
    Yang J; Gao H; Zhang Z; Tang C; Chen Z; Wang L; Yang F; Chen S; He S; Liu S; Tang L; Xu Y; Hu Y; Ma L; Zhao Y; Luo X
    Dermatol Ther; 2022 Aug; 35(8):e15648. PubMed ID: 35715972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study.
    Huang D; Zhang Y; Yu Y; Jiang Y; Kong L; Ding Y; Shi Y; Gao Y
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111157. PubMed ID: 37925949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT.
    Murrell DF; Joly P; Werth VP; Ujiie H; Worm M; Mangold AR; Avetisova E; Maloney J; Laws E; Mortensen E; Dubost-Brama A; Shabbir A
    Adv Ther; 2024 Jul; 41(7):2991-3002. PubMed ID: 38443648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review.
    Liang J; Abulikemu K; Maolidan ; Hu F; Zhao J; Qiu Y; Wang Q; Sang Y; Hong Y; Kang X
    Int Immunopharmacol; 2023 Mar; 116():109788. PubMed ID: 36731156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series.
    Abdat R; Waldman RA; de Bedout V; Czernik A; Mcleod M; King B; Gordon S; Ahmed R; Nichols A; Rothe M; Rosmarin D
    J Am Acad Dermatol; 2020 Jul; 83(1):46-52. PubMed ID: 32179082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
    Sticherling M; Franke A; Aberer E; Gläser R; Hertl M; Pfeiffer C; Rzany B; Schneider S; Shimanovich I; Werfel T; Wilczek A; Zillikens D; Schmidt E
    Br J Dermatol; 2017 Nov; 177(5):1299-1305. PubMed ID: 28494097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients.
    Miller AC; Temiz LA; Adjei S; Duran MA; Sassmannshausen J; Dominguez A; Thomas C; Schmidt JD; Bernhardt M; Doolittle-Amieva CJ; Moshiri AS; Thompson AJ; Pyoung Kim-Lim P; Mattia AV; Tyring SK
    J Drugs Dermatol; 2024 Jun; 23(6):e144-e148. PubMed ID: 38834228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab for bullous pemphigoid with intractable pruritus.
    Seidman JS; Eichenfield DZ; Orme CM
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
    Masuyuki R; Sato E; Imafuku S
    J Dermatol; 2024 Sep; 51(9):1252-1255. PubMed ID: 38507442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Dupilumab for the treatment of bullous pemphigoid.
    Wang M; Wang J; Shi B
    Dermatol Ther; 2022 Jul; 35(7):e15541. PubMed ID: 35478478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab.
    Bruni M; Moar A; Schena D; Girolomoni G
    Dermatol Online J; 2022 Mar; 28(2):. PubMed ID: 35670683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: A cluster analysis.
    Li J; Chen X; Zhu X; Shang P; Wang M
    J Dermatol Sci; 2024 Oct; 116(1):24-33. PubMed ID: 39358056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Dupilumab in Patients With Bullous Pemphigoid.
    Zhao L; Wang Q; Liang G; Zhou Y; Yiu N; Yang B; Zhang G; Li W; Feng S; Shang P; Chen X; Zhu X; Zheng J; Pan M; Wang M
    JAMA Dermatol; 2023 Sep; 159(9):953-960. PubMed ID: 37531116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.
    Yan T; Xie Y; Liu Y; Shan Y; Wu X; Wang J; Zuo YG; Zhang Z
    Front Immunol; 2023; 14():1194088. PubMed ID: 37575240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature.
    Saleh M; Reedy M; Torok H; Weaver J
    Dermatol Online J; 2021 Apr; 27(4):. PubMed ID: 33999579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.